Evidence map›Paper›PMID 37893152›Full record

ArticleBiomedicines2023

Synergistic Antimicrobial Effect of Cold Atmospheric Plasma and Redox-Active Nanoparticles.

Artem M Ermakov, Vera A Afanasyeva, Alexander V Lazukin, Yuri M Shlyapnikov, Elizaveta S Zhdanova, Anastasia A Kolotova, Artem S Blagodatski, Olga N Ermakova, Nikita N Chukavin, Vladimir K Ivanov and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Artem M ErmakovHospital of the Pushchino Scientific Center of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Vera A AfanasyevaHospital of the Pushchino Scientific Center of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Alexander V LazukinTroitsk Institute of Innovative and Thermonuclear Research (JSC "SSC RF TRINITY"), 108840 Moscow, Russia.
Yuri M ShlyapnikovInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Elizaveta S ZhdanovaHospital of the Pushchino Scientific Center of the Russian Academy of Sciences, 142290 Pushchino, Russia.ORCID 0000-0002-2390-8463
Anastasia A KolotovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Artem S BlagodatskiInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Olga N ErmakovaInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Nikita N ChukavinInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.ORCID 0000-0001-8431-4485
Vladimir K IvanovKurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-2343-2140
Anton L PopovInstitute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.ORCID 0000-0003-2643-4846
Institute of Theoretical and Experimental Biophysics · RURussian Academy of Sciences · RUNS Kurnakova Institute of General and Inorganic Chemistry · RUTroitsk Institute for Innovation and Fusion Research · RU

Funding

Ministry of Science and Higher Education of the Russian Federation No. FNSZ-2023-0008
6 · The paper itself

Abstract

Cold argon plasma (CAP) and metal oxide nanoparticles are well known antimicrobial agents. In the current study, on an example of

Indexed as

antimicrobial effectbacteriacerium fluoridecerium oxidecold argon plasmacombined treatmentnanoparticlestungsten oxide

Identifiers

PMID37893152
PMCPMC10604215
OpenAlexW4387615662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.